WMH adheres to Health Canada’s “Access to Cannabis for Medical Purposes Regulations” (ACMPR). To be eligible for Medical Cannabis a patient requires an up to date medical referral confirming their diagnosis by a family physician.
Medical cannabinoid research and clinical applications are slowly beginning to expand. We need more research funding to ensure that our patients are treated safely. The following is a preliminary study that illustrates an acute effect of a chronic condition. Hopefully this will spur more research in the field of hypertension and vascular risk factors.